If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Directorate Change

14 Jun 2012 16:15

RNS Number : 4114F
Arden Partners plc
14 June 2012
 



14 June 2012

 

Arden Partners plc ("Arden" or the "Company")

Directorate Change

The Board of Arden are pleased to announce the appointment of James Clive Reed-Daunter as an Executive Director of the Company with immediate effect following regulatory approval by the FSA.

Mr Reed-Daunter, 42, is a member of the senior management team at Arden and has a beneficial holding of 1,185,251 ordinary shares of 10 pence each in the Company, representing 4.78 per cent of the current issued share capital of the Company.

There is no other information that is required to be disclosed under schedule 2(g) of the AIM rules for Companies.

 

Arden Partners plc

0207 614 5900

Jonathan Keeling - Chief Executive Officer

 

Trevor Norris - Group Finance Director

 

 

 

Altium - NOMAD to Arden Partners plc

0207 484 4040

Phil Adams

 

Sam Fuller

 

 

Buchanan Communications

0207 466 5000

Mark Edwards

 

Nicola Cronk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABUGDLLGBBGDS
Date   Source Headline
22nd Jan 201011:17 amRNSEPT Disclosure
20th Jan 201010:46 amRNSEPT Disclosure
11th Jan 201011:32 amRNSEPT Disclosure
7th Jan 201011:53 amRNSEPT Disclosure
5th Jan 201011:01 amRNSEPT Disclosure
4th Jan 201011:24 amRNSEPT Disclosure
31st Dec 200910:04 amRNSEPT Disclosure
23rd Dec 200911:46 amRNSEPT Disclosure
22nd Dec 200911:09 amRNSEPT Disclosure
21st Dec 200911:46 amRNSEPT Disclosure
18th Dec 20093:59 pmRNSEPT Disclosure
11th Dec 200911:30 amRNSEPT Disclosure
26th Nov 200911:59 amRNSEPT Disclosure
25th Nov 200911:40 amRNSEPT Disclosure
23rd Nov 200910:07 amRNSBlocklisting Return
16th Nov 200910:29 amRNSEPT Disclosure
2nd Nov 200911:38 amRNSTotal Voting Rights
14th Sep 20094:08 pmRNSEBT purchase
4th Sep 200911:20 amRNSEPT Disclosure
1st Sep 20091:59 pmRNSTotal Voting Rights
1st Sep 200910:31 amRNSEPT Disclosure
25th Aug 200910:01 amRNSEPT Disclosure
20th Aug 200911:23 amRNSEPT Disclosure
19th Aug 200911:29 amRNSEPT Disclosure
18th Aug 200910:24 amRNSEPT Disclosure
14th Aug 200910:21 amRNSEPT Disclosure
13th Aug 200911:28 amRNSEPT Disclosure
11th Aug 200911:41 amRNSEPT Disclosure - Amendment
11th Aug 200911:24 amRNSEPT Disclosure
10th Aug 20099:47 amRNSEPT Disclosure
6th Aug 20099:47 amRNSEPT Disclosure
5th Aug 200910:48 amRNSEPT Disclosure
31st Jul 20099:29 amRNSEPT Disclosure
30th Jul 200910:45 amRNSEPT Disclosure
24th Jul 20091:16 pmRNSDirector's dealing
24th Jul 200910:08 amRNSEPT Disclosure
23rd Jul 20099:19 amRNSEPT Disclosure
17th Jul 20091:44 pmRNSEBT Purchase
14th Jul 20097:00 amRNSInterim results
10th Jul 200910:08 amRNSEPT Disclosure
9th Jul 20099:56 amRNSEPT Disclosure
3rd Jul 20097:00 amRNSNotice of Results
1st Jul 20099:31 amRNSEPT Disclosure
25th Jun 20099:52 amRNSEPT Disclosure
24th Jun 200911:01 amRNSEPT Disclosure
23rd Jun 200910:17 amRNSEPT Disclosure
15th Jun 200912:13 pmRNSAndrew Heath Appointed Head of Equities
12th Jun 200910:43 amRNSEPT Disclosure
11th Jun 200910:15 amRNSEPT Disclosure
10th Jun 200910:26 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.